Albert Lochbronner

Placeholder Person Graphic
Merck KgaA
Director, IT Validation
Albert Lochbronner has an engineering degree in computer sciences from Ulm University of Applied Sciences. He has over 25 years of experience in the area of IT compliance in GxP environments including infrastructure qualification, validation of computerized systems, and data integrity. Albert’s expertise comprises validation strategies for innovative digital technologies such as mobile computing, cloud-based solutions, and artificial intelligence. He is an experienced software quality assurance auditor and a certified data protection officer. Albert is currently Director, IT Validation, at Merck KGaA where he leads a team that provides validation services to the company’s major information management systems. He has been an ISPE member since 2019.

Related Articles

Figure 3: Overview of AI application fields in the pharmaceutical production process and value chain.
Technical
AI Governance and QA Framework: AI Governance Process Design

Artificial intelligence (AI) has the potential to benefit the pharmaceutical industry and its GxP-regulated areas. Several pharmaceutical companies are currently running digital pilots; 90% of large pharmaceutical companies have initiated AI projects.1

  • 1Trinity Life Sciences. “Ninety Percent of Large Pharma Companies Initiated Artificial Intelligence/Machine Learning Projects In...